Concepedia

Author

Huiping Guan

AstraZeneca (United States)

Also Known As

Huiping Amy Guan, Huiping Guan

8

Publications

310

Citations

7

H-Index

14

Concepts

All Affiliations

AstraZeneca (United States)AstraZeneca (United Kingdom)
HG

About

Huiping Guan is an author at AstraZeneca (United States) specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

164

2

Natural Sciences

3

3

142

3

Biochemistry

3

3

102

4

Chemical Biology

2

2

87

5

Molecular Biology

1

1

62

Huiping Guan

×

6

Publications

298

Citations

6

H-Index

YearCitations

SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity

Shem Patyna, Alexander Laird, Dirk B. Mendel,

Molecular Cancer Therapeutics

2006

102

Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering

Jeffrey W. Johannes, Lynsie Almeida, Kevin Daly,

Bioorganic & Medicinal Chemistry Letters

2015

62

Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase

Huiping Guan, Alexander Laird, Robert A. Blake,

Bioorganic & Medicinal Chemistry Letters

2003

55

Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS

Hilary S. Eidam, John P. Russell, Kaushik Raha,

ACS Medicinal Chemistry Letters

2018

32

Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: Discovery of potent and selective JAK2 inhibitors

Stephanos Ioannidis, Michelle L. Lamb, Lynsie Almeida,

Bioorganic & Medicinal Chemistry Letters

2010

25

Discovery of novel Jak2–Stat pathway inhibitors with extended residence time on target

Huiping Guan, Michelle L. Lamb, Bo Peng,

Bioorganic & Medicinal Chemistry Letters

2013

22

Page 1